Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Unveiling Key Stock Market Trends

Large-cap Finance company Series has logged a 2.6% change today on a trading volume of 2,504,053. The average volume for the stock is 3,028,690.

Marsh & McLennan Companies, Inc., a professional services company, provides advisory services and insurance solutions to clients in the areas of risk, strategy, and people worldwide. Based in New York, United States the company has 95,000 full time employees and a market cap of $79,712,894,976. Series currently offers its equity investors a dividend that yields 2.2% per year.

The company is now trading -18.19% away from its average analyst target price of $202.24 per share. The 21 analysts following the stock have set target prices ranging from $179.0 to $236.0, and on average give Series a rating of buy.

Over the last 12 months MRSH shares have declined by -31.3%, which represents a difference of -58.4% when compared to the S&P 500. The stock's 52 week high is $233.5 per share and its 52 week low is $156.6. Based on Series's average net margin growth of 4.3% over the last 6 years, its core business remains strong and the stock price may recover in the long term.

Date Reported Total Revenue ($ k) Net Profit ($ k) Net Margins (%) YoY Growth (%)
2025 26,981,000 4,160,000 15 -11.76
2024 24,458,000 4,060,000 17 0.0
2023 22,736,000 3,756,000 17 13.33
2022 20,720,000 3,050,000 15 -6.25
2021 19,820,000 3,143,000 16 33.33
2020 17,224,000 2,016,000 12
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS